Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Duffau

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2023
Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study)Jihane Ben Farhat, Mojgan Hessamfar, Sophie Farbos, et al.
Science Translational Medicine|September 3, 2010
Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosusPierre Duffau, Julien Seneschal, Carole Nicco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Severe Bacterial Non-AIDS Infections in Persons With Human Immunodeficiency Virus: The Epidemiology and Evolution of Antibiotic Resistance Over an 18-Year Period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine CohortPeggy Blanc, Fabrice Bonnet, Olivier Leleux, et al.
AIDS (London, England)|October 26, 2017
Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patientsRodolphe Thiébaut, Sophie Hue, Fabien Le Marec, et al.
Arthritis Research & Therapy|May 20, 2021
Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritisHubert de Boysson, Maelle Le Besnerais, Félix Blaison, et al.
AIDS and Behavior|January 5, 2025
Exposure to COVID-19 Pandemic-Related Stressors and Their Association With Distress, Psychological Growth and Drug Use in People With HIV in Nouvelle Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliV-QuAliCOV Study)Jihane Ben Farhat, Mojgan Hessamfar, Didier Neau, et al.
Brain and Behavior|September 16, 2024
Neurosarcoidosis: Clinical, biological, and MRI presentation of central nervous system disease in a national multicenter cohortAmélie Dos Santos, Edouard Courtin, Aurélie Ruet, et al.
JAMA Network Open|July 8, 2022
Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated VasculitisSara Thietart, Alexandre Karras, Jean-François Augusto, et al.
AIDS (London, England)|March 17, 2023
Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesisFlorent Guerville, Marine Vialemaringe, Celine Cognet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus ErythematosusLiliane Khoryati, Jean-François Augusto, Emilie Shipley, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2023
Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study)Jihane Ben Farhat, Mojgan Hessamfar, Sophie Farbos, et al.
Science Translational Medicine|September 3, 2010
Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosusPierre Duffau, Julien Seneschal, Carole Nicco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Severe Bacterial Non-AIDS Infections in Persons With Human Immunodeficiency Virus: The Epidemiology and Evolution of Antibiotic Resistance Over an 18-Year Period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine CohortPeggy Blanc, Fabrice Bonnet, Olivier Leleux, et al.
AIDS (London, England)|October 26, 2017
Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patientsRodolphe Thiébaut, Sophie Hue, Fabien Le Marec, et al.
Arthritis Research & Therapy|May 20, 2021
Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritisHubert de Boysson, Maelle Le Besnerais, Félix Blaison, et al.
AIDS and Behavior|January 5, 2025
Exposure to COVID-19 Pandemic-Related Stressors and Their Association With Distress, Psychological Growth and Drug Use in People With HIV in Nouvelle Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliV-QuAliCOV Study)Jihane Ben Farhat, Mojgan Hessamfar, Didier Neau, et al.
Brain and Behavior|September 16, 2024
Neurosarcoidosis: Clinical, biological, and MRI presentation of central nervous system disease in a national multicenter cohortAmélie Dos Santos, Edouard Courtin, Aurélie Ruet, et al.
JAMA Network Open|July 8, 2022
Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated VasculitisSara Thietart, Alexandre Karras, Jean-François Augusto, et al.
AIDS (London, England)|March 17, 2023
Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesisFlorent Guerville, Marine Vialemaringe, Celine Cognet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus ErythematosusLiliane Khoryati, Jean-François Augusto, Emilie Shipley, et al.
Pageof 12